Cancer control at the workplace

The working well trial

David Abrams, W. Bryant Boutwell, James Grizzle, Jerianne Heimendinger, Glorian Sorensen, Jill Varnes

Research output: Contribution to journalArticle

Abstract

Background. Few research studies have been conducted on cancer prevention and control at the workplace. This article presents an overview of the largest worksite cancer control trial in the United States-The Working Well Trial-conducted in 114 worksites by four study centers, a coordinating center, and the National Cancer Institute. The trial′s organizational structure, research design, dependent measures, and theoretical model for intervention are described. Special features of the trial include using the worksite as the unit of randomization, intervention, and evaluation and a theory-driven conceptual model of intervention that places emphasis on individual and organizational targets for change, uses the transtheoretical stage of change model to guide a sustained 2-year multiple risk factor intervention, and makes use of volunteer resources within the worksite to reduce cost, increase participation, and improve tailoring to individual needs. The trial will have a potential impact on over 25,000 workers. Conclusion. The issues raised in this overview have implications for the evaluation and dissemination of cancer prevention and control programs to defined populations.

Original languageEnglish (US)
Pages (from-to)15-27
Number of pages13
JournalPreventive Medicine
Volume23
Issue number1
DOIs
StatePublished - 1994

Fingerprint

Workplace
Neoplasms
Organizational Innovation
National Cancer Institute (U.S.)
Random Allocation
Volunteers
Research Design
Theoretical Models
Costs and Cost Analysis
Research
Population

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Abrams, D., Boutwell, W. B., Grizzle, J., Heimendinger, J., Sorensen, G., & Varnes, J. (1994). Cancer control at the workplace: The working well trial. Preventive Medicine, 23(1), 15-27. https://doi.org/10.1006/pmed.1994.1003

Cancer control at the workplace : The working well trial. / Abrams, David; Boutwell, W. Bryant; Grizzle, James; Heimendinger, Jerianne; Sorensen, Glorian; Varnes, Jill.

In: Preventive Medicine, Vol. 23, No. 1, 1994, p. 15-27.

Research output: Contribution to journalArticle

Abrams, D, Boutwell, WB, Grizzle, J, Heimendinger, J, Sorensen, G & Varnes, J 1994, 'Cancer control at the workplace: The working well trial', Preventive Medicine, vol. 23, no. 1, pp. 15-27. https://doi.org/10.1006/pmed.1994.1003
Abrams D, Boutwell WB, Grizzle J, Heimendinger J, Sorensen G, Varnes J. Cancer control at the workplace: The working well trial. Preventive Medicine. 1994;23(1):15-27. https://doi.org/10.1006/pmed.1994.1003
Abrams, David ; Boutwell, W. Bryant ; Grizzle, James ; Heimendinger, Jerianne ; Sorensen, Glorian ; Varnes, Jill. / Cancer control at the workplace : The working well trial. In: Preventive Medicine. 1994 ; Vol. 23, No. 1. pp. 15-27.
@article{07be684fde7649508c4230bd971d9193,
title = "Cancer control at the workplace: The working well trial",
abstract = "Background. Few research studies have been conducted on cancer prevention and control at the workplace. This article presents an overview of the largest worksite cancer control trial in the United States-The Working Well Trial-conducted in 114 worksites by four study centers, a coordinating center, and the National Cancer Institute. The trial′s organizational structure, research design, dependent measures, and theoretical model for intervention are described. Special features of the trial include using the worksite as the unit of randomization, intervention, and evaluation and a theory-driven conceptual model of intervention that places emphasis on individual and organizational targets for change, uses the transtheoretical stage of change model to guide a sustained 2-year multiple risk factor intervention, and makes use of volunteer resources within the worksite to reduce cost, increase participation, and improve tailoring to individual needs. The trial will have a potential impact on over 25,000 workers. Conclusion. The issues raised in this overview have implications for the evaluation and dissemination of cancer prevention and control programs to defined populations.",
author = "David Abrams and Boutwell, {W. Bryant} and James Grizzle and Jerianne Heimendinger and Glorian Sorensen and Jill Varnes",
year = "1994",
doi = "10.1006/pmed.1994.1003",
language = "English (US)",
volume = "23",
pages = "15--27",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Cancer control at the workplace

T2 - The working well trial

AU - Abrams, David

AU - Boutwell, W. Bryant

AU - Grizzle, James

AU - Heimendinger, Jerianne

AU - Sorensen, Glorian

AU - Varnes, Jill

PY - 1994

Y1 - 1994

N2 - Background. Few research studies have been conducted on cancer prevention and control at the workplace. This article presents an overview of the largest worksite cancer control trial in the United States-The Working Well Trial-conducted in 114 worksites by four study centers, a coordinating center, and the National Cancer Institute. The trial′s organizational structure, research design, dependent measures, and theoretical model for intervention are described. Special features of the trial include using the worksite as the unit of randomization, intervention, and evaluation and a theory-driven conceptual model of intervention that places emphasis on individual and organizational targets for change, uses the transtheoretical stage of change model to guide a sustained 2-year multiple risk factor intervention, and makes use of volunteer resources within the worksite to reduce cost, increase participation, and improve tailoring to individual needs. The trial will have a potential impact on over 25,000 workers. Conclusion. The issues raised in this overview have implications for the evaluation and dissemination of cancer prevention and control programs to defined populations.

AB - Background. Few research studies have been conducted on cancer prevention and control at the workplace. This article presents an overview of the largest worksite cancer control trial in the United States-The Working Well Trial-conducted in 114 worksites by four study centers, a coordinating center, and the National Cancer Institute. The trial′s organizational structure, research design, dependent measures, and theoretical model for intervention are described. Special features of the trial include using the worksite as the unit of randomization, intervention, and evaluation and a theory-driven conceptual model of intervention that places emphasis on individual and organizational targets for change, uses the transtheoretical stage of change model to guide a sustained 2-year multiple risk factor intervention, and makes use of volunteer resources within the worksite to reduce cost, increase participation, and improve tailoring to individual needs. The trial will have a potential impact on over 25,000 workers. Conclusion. The issues raised in this overview have implications for the evaluation and dissemination of cancer prevention and control programs to defined populations.

UR - http://www.scopus.com/inward/record.url?scp=0028209528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028209528&partnerID=8YFLogxK

U2 - 10.1006/pmed.1994.1003

DO - 10.1006/pmed.1994.1003

M3 - Article

VL - 23

SP - 15

EP - 27

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 1

ER -